-+ 0.00%
-+ 0.00%
-+ 0.00%

Fresenius Improves FY26 Core EPS Growth Outlook, Revenue Guidance Affirmed

MT Newswires·11/04/2026 01:30:12
Listen to the news
01:30 AM EST, 11/04/2026 (MT Newswires) -- Fresenius (FRE.F) improved its core EPS growth guidance for full-year 2026, according to a Wednesday filing. The therapy-focused healthcare company now expects core EPS growth in the upper half of the 10% to 15% range in constant currency, compared with earlier forecasts within the 10% to 15% range. Meanwhile, the company reiterated its organic revenue growth guidance of between 4% and 7%.